Who benefits from antibiotics?
26 October 2017
Roderick Venekamp received a Veni, a personal grant for outstanding researchers who have just been awarded their PhDs. Over the next four years, he will use this grant to investigate which adults with acute sinus and throat symptoms benefit from antibiotics.
Roderick explains: "I am going to apply new methodological and statistical techniques to existing data sets. In this way, I hope to be able to identify groups that would benefit from antibiotics in two common conditions encountered by GPs: sinusitis and throat infections." What makes this research special?
Roderick explains: "General practice and research really come together here. I am using new research techniques which have been adopted by the Julius Center. By applying them to examinations already carried out in general practice, I hope to be able to draw more specific conclusions about subgroups of patients or patient profiles who will or will not benefit from antibiotics." He stresses: "Depending on the condition, we know that about fifty to seventy percent of patients receive antibiotic therapy, whereas this treatment is barely effective for the average patient with these complaints. So there is much to be gained from giving GPs tools that put them in a better position to decide who is and who is not likely to benefit from antibiotic treatment. And although things are generally pretty good in the Netherlands, increasing resistance means it is important that we prescribe antibiotics effectively."
Roderick has been working at the Julius Center since 2008. He is a part-time GP in Waalwijk. The Veni will allow him to continue to combine his work as a general practitioner with his role as a researcher at the Julius Center.